News - Abatacept
PARIS, May 14, 2012 /PRNewswire/ -- - Results of head-to-head study comparing two biologic drugs on a background of methotrexate for the treatment
NEW YORK, June 8, 2011 /PRNewswire/ -- One of the major annual rheumatology conferences, the European League Against Rheumatism's Congress (EULAR), was held May 25-28 in London.
EXTON, Pa., Dec. 20, 2010 /PRNewswire/ -- In its recently released annual 2010 update, ChartTrends®: Biologics in Rheumatoid Arthritis, BioTrends Research Group, Inc.
Today, individuals with lupus nephritis benefit from better treatments than a decade ago.
Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE).
